Other languages Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
3.07 ^USD	+0.33%		+2.68%	-4.66%

04-30	B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	MT
04-29	HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-08
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-08
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-03
Ligand Acquires 13% Stake in Ovid Therapeutics' Soticlestat Royalties for $30 Million	18/10/23
Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23
Ovid Therapeutics Inc. Announces Changes to Its Board	28/06/23
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	05/05/23
Ovid Therapeutics Inc. Enters into an Exclusive Collaboration and License Agreement with Graviton Bioscience Corporation	01/05/23
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	13/03/23
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	13/03/23
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	13/03/23
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	13/03/23
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments	08/02/23
Ovid Therapeutics Doses Healthy Volunteers with OV329 in Phase 1 Trial	05/01/23
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/11/22
Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22
ANALYSE/"Long Covid" ist für große Pharmakonzerne schwer zu packen	11/07/22
Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $1.4M	10/05/22
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Other languages

Filters